Oxford BioMedica PLC
F:OXOA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
O
|
Oxford BioMedica PLC
F:OXOA
|
UK |
|
A
|
Anchun International Holdings Ltd
SGX:BTX
|
CN |
|
Bank of Labor Bancshares Inc
OTC:BHDB
|
US |
|
T
|
Targa Exploration Corp
OTC:TRGEF
|
CA |
|
E
|
Ever-Glory International Group Inc
F:E4GA
|
CN |
|
P
|
Panoramic Resources Ltd
XMUN:YM1
|
AU |
|
J
|
Jumbo Interactive Ltd
F:JUB
|
AU |
|
H
|
Harmony Acquisitions Corp
XTSX:MONY.P
|
CA |
|
D
|
Doosan Skoda Power as
F:J3G
|
CZ |
|
S
|
Sunflex Technology Co Ltd
TPEX:3390
|
TW |
|
A
|
Altamira Gold Corp
F:T6UP
|
CA |
|
I
|
Inzi Display Co Ltd
KOSDAQ:037330
|
KR |
|
S
|
Sugih Energy Tbk PT
IDX:SUGI
|
ID |
|
The Cochin Malabar Estates and Industries Ltd
BSE:508571
|
IN |
|
D
|
Dignity PLC
F:DN8E
|
UK |
|
Scorpio Gold Corp
F:RY9
|
CA |
|
M
|
Madison Pacific Properties Inc
TSX:MPC
|
CA |
|
Blue Water Petroleum Corp
OTC:BWPC
|
US |
Bankruptcy Probability
Oxford BioMedica PLC's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Oxford BioMedica PLC Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| UK |
|
Oxford BioMedica PLC
LSE:OXB
|
612.2m GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
470B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
239.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
183.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
139.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
86.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
69.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
55.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Oxford BioMedica PLC's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Oxford BioMedica PLC has total debt of 142.1m GBP. This includes both short-term (0 GBP) and long-term (142.1m GBP) debt.
You can find a full breakdown on its Balance Sheet.
